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Within the past several decades disorders with deranged
transport functions in renal proximal tubule cells have become
clinically prominent. Every textbook of medicine or pediatrics
contains a discussion of inherited or acquired diseases involving
defects in the absorption of specific amino acids, sugars, or
other solutes. The inherited disorders may involve specific
amino acids, such as in classic cystinuria with dibasic aminoac-
iduria, iminoglycinuria, and i-Iartnup disease with neutral ami-
noaciduria, sugars as in renal glycosuria and glucose-galactose
malabsorption, or phosphate as in hypophosphatemic rickets or
uric acid. Although the exact defect in cell function in these
disorders has not been delineated, the likely explanation has
been that they result from a malfunctioning or absent specific
carrier mechanism for the transport of the particular substances
involved. The renal Fanconi syndrome (Dc Toni-Debré-Fan-
coni syndrome), which has been thoroughly discussed by
Morris et al [I] and by Brodehl [21, on the other hand, is
characterized by a generalized disorder in proximal renal tubule
transport affecting amino acids, glucose, and phosphate, as well
as uric acid, bicarbonate, and other substances. The clinical
consequences are acidosis, rickets, impaired growth. polyuria,
dehydration, and hypokalemia.
Besides being manifested by a global dysfunction of renal
transport mechanisms, the Fanconi syndrome is associated
with numerous disease states ranging from rare inherited disor-
ders of metabolism to exposure to exogenous toxins. In most
cases, the causation of the abnormal renal function is multifac-
tonal, with a host of genetic and toxic factors being implicated
in the pathogenesis. Thus, the Fanconi syndrome may be the
final common pathway for the phenotypic expression of diverse
inherited and acquired perturbations of renal tubule function.
The diversity of the underlying metabolic derangements, both
acute and chronic, suggests there may be a common step
necessary for normal membrane transport upon which many
factors may impinge. In contrast to carrier" abnormalities in
specific aminoacidunias, the widespread derangement of renal
tubule function in the Fanconi syndrome could result froni
disordered cell metabolism which is specifically linked to
energy transduction to membranes or to disordered membrane
structure as a primary or secondary event.
An understanding of the basic underlying mechanism of the
Fanconi syndrome is important not only to the clinician who
deals with the consequences in the patient but also to the renal
physiologist and cell biologist attempting to fathom the cellular
processes of membrane transport. It is the intent of this review
to colTelate available knowledge of the transport dysfunction
gathered from clinical studies in humans and from the investiga-
tion of animal models. To provide proper perspective with
regard to present knowledge of normal transport processes for
various substrates, we will discuss the major features of the
syndrome under the topics of hyperaminoaciduria. glycosuria.
and phosphaturia. It is hoped that this review will provide both
insights for the present and stimulation for future investigation.
Hyperaminoaciduria
One of the hallmarks of the Fanconi syndrome is a general-
ized excessive urinary excretion of amino acids resulting from a
defect in renal tubular handling. In normal children only I to 6
mg of amino acids per kilogram of body wt per day are excreted
because over 98% of the filtered load of amino acids (except for
aspartic acid, glycine and histidine where 94 to 98% is reab-
sorbed) is reabsorbed in the proximal tubule. But, in the
Fanconi syndrome, there is a marked generalized increase in
the urinary excretion of amino acids.
Clinical un'estigations. The degree and pattern of this hyper-
aminoacidunia in the Fanconi syndrome varies from disease to
disease and even from patient to patient with a particular
disease associated with the Fanconi syndrome. Brodehl found
in 6 patients with the Fanconi syndrome that a pattern of amino
acid excretion tended to mimic that of the normal, that is, those
amino acids with relatively high excretion rates were affected
more than those with relatively low excretion rates [31. Manz.
Bremer, and Brodehl [4] also noted that in 6 patients with
Lowe's syndrome that, although there was a generalized in-
crease in amino acid excretion, cystine and dibasic amino acids
were excreted more than the other amino acids were. We.
however, were unable to dicern a clear pattern of amino acid
excretion in our patients with the Fanconi syndrome associated
with several diseases (Table I). In all of our patients, histidine
excretion was within a normal range, but this was one of the
more affected amino acids in Brodehl's patients. In our patients
with Lowe's syndrome, the excretion of cystine and the dibasic
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amino acids was several-fold greater than normal, yet the
excretion of other amino acids was even greater.
The nature of the defect underlying this excessive amino acid
excretion remains enigmatic. Amino acid transport in the
human kidney appears to involve specific carriers for groups of
amino acids, even specific carriers for individuals amino acids.
Evidence for this in the human comes from specific, heritable
defects in amino acid absorption involving several amino acids,
such as iminoglycinuria, Hartnup disease, classical cystinuria,
and hyperdibasic aminoaciduria or even involving single amino
acids, such as isolated cystinuria and glucoglycinuria. Further
evidence for the specificity of these carriers for groups of amino
acids comes from the infusion of a specific amino acid in normal
subjects which has reproduced the amino acid excretion pattern
observed in several of these aminoacidurias. Examples of this
are the infusion of lysine, which increased cystine, ornithine
and arginine excretion [5, 6], and the infusion of proline, which
increased glycine excretion [7]. Additional support for carrier-
mediated transport comes from studies using renal cortex slices
from humans where glycine uptake was shown to he concentra-
tive, sodium dependent, and inhibited by proline {8j. Dibasic
amino acids were also actively transported by human renal
cortex and appear to share a common transport system which
was thought to be defective in patients with cystinuria, although
an interaction of cystine with this system could not be shown
using renal cortical slices. Neither could defective cystine
transport be demonstrated in patients with cystinuria using
renal cortical slices [91. But, with the advent of newer in vitro
techniques for studying amino acid transport, the isolated renal
cortical tubule and the renal brushborder membrane vesicle,
cystine, and dibasic amino acids were shown to share a
common transport system in the rat proximal tubule which was
not demonstrable using cortical slices [10, II]. This system
probably also exists in the human and may be defective in
classical cystinuria.
In the Fanconi syndrome, the generalized nature of the
aminoaciduria militates against a specific defective carrier. A
more likely explanation would be a disorder of energy genera-
tion or of the coupling of energy generation to the process of
amino acid uptake. Amino acid transport in the kidney is
dependent on energy since transport in renal cortex slices is
sharply curtailed with anaerobiosis or metabolic inhibitors [121.
Some support for a defect in energy production leading to
aminoaciduria comes from the infusion of fructose in patients
with hereditary fructose intolerance which leads rapidly to
aminoaciduria coincident with accumulation of intracellular
fructose-i-phosphate and depletion of intracellular phosphate
[I]. Infusion of phosphate concomitant with fructose attenuated
Type
Table 1. Amino acid excretion in various types of the Fariconi syndrome
24-Hr urinary amino acid excretion
Normal 2 to 4x 5 to lOx lOx
Cystinosis (N = 6) ASP,THR PRO.CIT
ASN,GLN VAL
GLY ,ALA
CYS,ILE
TYR,LEU
PHE,DRN
ARO
Lowe's syndrome (N = 2)h
Lowe's syndrome (N =
Tyrosinemia (N = 1)
Idiopathic (N = 1) HIS MET,TYR THR,SER
LYS GLU,PRO
GLY,ALA
CYS,VAL
LEU,ILE
ARG.PHE
Headings denote the increase above normal. N denotes the number of patients studied. Abbreviations are defined as follows:
ASN—asparagine ASP—aspartic acid ARG—arginine
ALA—alanine CYS—cystine CIT—citrulline
GLN—glutamine GLU—glutamic acid G LY—glycine
HIS—histidine ILE—isoleucine LYS—lysine
LEU—leucine MET—methionine PH E—phenylalanine
PRO—proline SER—serine THR—threonine
TYR—tyrosine TRY—tryptophan VAL—valine
"Three patients with the same disease had two different patterns of amino acid excretion.
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the aminoaciduria, suggesting that the intracellular phosphate
depletion with possible reduction in ATP and other high-energy
phosphate compounds may underlie the renal tubular dysfunc-
tion in hereditary fructose intolerance [I]. Another possible
explanation for the generalized defect in amino acid handling is
a primary disorder of the lipid bilayer of the membrane allowing
increased efflux of the transported amino acids similar to the
Fanconi syndrome induced by the exposure of renal tubule cells
to maleic acid both in vivo and in vitro [13—161. There could also
be a portion of the carrier or a subunit that is common to all the
carriers and necessary for insertion or orientation in the mem-
brane. This could be defective in certain forms of the Fanconi
syndrome leading to the renal tubule dysfunction. Also, sodium
has been shown to be important in the transport of many
substrates across the brushborder membrane and a defect in the
binding of this ion by the carrier or maintenance of proper
sodium flux across the cell could lead to the Fanconi syndrome.
Laboratory ini'estigat!ons. Developmental studies in animal
models. Just as the human neonatal urine contains an abun-
dance of various amino acids 1171, so too does the urine of
newborns from other species. The pattern, however, of this
aminoaciduria changes from species to species and varies, as
well, from one individual to another within a particular species.
Nonetheless, the persistent finding of increased renal clearance
of a number of amino acids in the newborn rat, for example, has
provided investigators with a physiologic model for study of
mechanisms for aminoacidurias. Using this model, investiga-
tors have described many changes in various amino acid
transport mechanisms which occur with development of the
kidney.
Perhaps the most extensively investigated of the amino acid
transport systems in the developmental model is the iminogly-
cine system. Particular attention was originally drawn to this
system by the description of an iminoglycinuric syndrome in
man [181 and by the finding of massive prolinuria and glycinuria
in newborn rats [191. Such a finding suggests that the newborn
renal tubule might be less capable of active accumulation of
glycine and proline than the adult tubule as reflected by
decreased intracellular pools of these amino acids in newborn
renal cortex. Recent infusion studies in iminoglycinuric patients
support this view [201. To the contrary, however, in vivo
glycine pools are significantly higher in newborn cortex while
the glycine concentration gradient established by newborn renal
cortex over newborn plasma is 1.3 times higher than in the adult
[2!].
In vitro investigations of glycine uptake in rat kidney cortex,
using both the slice [22, 23] and isolated tubule [24, 25] models,
have shown no impairment ofglycine entry in newborn tissue in
physiologic concentrations. Although it is not possible to differ-
entiate brushborder transport events from those occurring at
the antiluminal surface in the above models, a recent study of
glycine uptake by rat kidney brushborder membrane vesicles
yielded results very similar to those obtained from intact cell
preparations [26]. Thus, the problem becomes one of explaining
the decreased tubular reabsorption in the newborn where there
is strong evidence for normal adult level uptake in vitro.
Indeed, the answer may lie in the fact that the loss from the cell
(efflux) of accumulated material is far slower in newborn tissue
[22, 271. This finding certainly explains the higher intracellular
amino acid pool, as well as the greater concentration gradient in
newborn cortex. If the major portion of efflux occurs across the
antiluminal surface of the tubule, then influx at the hrushborder
surface may be slowed in a secondary fashion by the high
intracellular levels in the newborn [221. This mechanism has
also been postulated for the uptake of proline in the prolinuric
(PRO/Re) mouse kidney [28].
Using the neutral amino acid transport analogue, s-aminoiso-
butyric acid (AIB), Roth, Goldman, and Segal [16] have investi-
gated the in vitro effect of 6 m maleic acid on the neutral
amino acid uptake system during development of the rat
kidney. Although maleic acid is known to significantly diminish
the capacity of mature renal cortical slices and isolated tubules
to concentrate AIB [14], no impairment of newborn uptake
could be demonstrated. But, as the rate of efflux increased as a
function of age, so too did the degree of impairment increase in
AIB uptake by the tubule. These observations are consistent
with those of Bergeron, Scriver, and Mohyuddin [19] obtained
with a microperfusion technique in adult rats treated with
maleate, which indicated that the aminoaciduria was a conse-
quence of increased efflux of normally accumulated amino
acids. Although the basic mechanism by which maleate creates
aminoaciduria in animals continues to elude investigators, the
answer must be found in studying the manner in which maleate
affects efflux.
The developmental approach to renal amino acid transport
has also been used in the study of cystinuria, in which there is
increased urinary excretion of cystine and the dibasic amino
acids, arginine, ornithine, and lysine. Using renal cortical
slices, Segal and Smith [29] showed impaired cystine uptake in
newborn slices but they found that lysine uptake was compara-
ble to that in adult slices. In a separate study, the same authors
also reported that cysteine uptake in the newborn was compara-
ble to that of an adult [301. These observations document the
separate nature of the transport systems for cystine, cysteine.
and lysine. The relevance of these data to an understanding of
the Fanconi syndrome remains univestigated, although Rosen-
berg and Sega! [14] demonstrated a correlation between a
massive lysinuria produced in adult rats by injection of maleic
acid and impaired uptake in vitro of lysine by adult rat kidney
slices treated with maleate.
Effects of maleate in animal models. Maleic acid has been
used in a number of ways in attempts to elucidate the mecha-
nism by which it causes aminoaciduria in animals in vivo and
impairs amino acid transport in vitro. Interestingly. Rosenberg
and Segal [14] were unable to show histologic changes in the
kidneys of treated rats within 1, 2, or 4 hours after injection of
maleate, consistent with a biochemical effect of relatively rapid
onset. The nature of this biochemical effect was suggested by
earlier reports [31, 32] in which a rapid binding of free sulfhy-
dryl groups by maleic acid had been demonstrated. A subse-
quent report by Patrick [331 demonstrated a decrease in the
activities of SH-dependent enzymes in the livers of cystinotic
children. The data presented in the same report for renal
enzymes, however, must be interpreted with great care, since
the end-stage kidney in cystinosis is so scarred and fibrotic as to
be almost unrecognizable. The applicability of data derived
from studies in liver to events occurring in the kidney of
children with cystinosis must remain in doubt, because the
clinical findings of the disease focus primarily on renal dysfunc-
tion. Furthermore, Rosenberg and Sega! [14] demonstrated
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selective penetration of maleic acid into rat kidney tissue,
whereas Taggart, Angielski, and Morell [341 demonstrated a
relatively rapid rate of metabolic conversion of labeled maleate
to carbon dioxide by a rabbit kidney compared to the liver. This
conversion depends on the presence of maleate hydratase
which converts the maleate to D( + )malate with further conver-
sion of the latter to fumarate and subsequent entry into the
Krebs cycle. All of these observations indicate the likelihood of
qualitatively and/or quantitatively different effects of maleate
on liver and kidney.
Recent work [35, 36] has implicated an effect of maleate on
substrate-level oxidations in kidney mitochondria as the under-
lying biochemical event in the production of the experimental
Fanconi syndrome. The postulated mechanism suggests that
maleic acid is converted to maleyl-CoA through the action of a
CoA-transferase on the succinyl-CoA formed through the
Krebs cycle. The maleyl-CoA is thus assumed to react further
to form a dithioether, a more stable compound than succinyl-
CoA, causing a shift in equilibrium toward the former and
constituting, in effect, a metabolic "sink." The liver is known
to be deficient in CoA-transferase, thus explaining the resist-
ance of liver mitochondria to maleate and underscoring the
earlier statement about interpretation of renal events from
experiments performed on liver tissue. Anglelski and Szcze-
panska [37] have performed in vivo experiments in which they
have tested their hypothesis by simultaneously infusing i.v.
acetoacetate with maleic acid into rats and demonstrate a
protective effect of the acetoacetate on renal reabsorption of
bicarbonate and phosphate. This effect they attributed to a
competition between acetoacetate and maleic acid for the
transfer ofCoA through the action of the CoA transferase. But,
they were unable to show a correlation between maleic acid's
effect on renal function and impaired mitochondrial ATP syn-
thesis. Their conclusion from this work stated that maleic acid
exerts its inhibitory effects on transport through an action on
membrane SH groups involved in the transport process. Thus,
they were unable to clearly demonstrate a link between the
metabolic and transport inhibition exerted by maleic acid.
A parallel approach to an understanding of the maleic acid
effect on renal tubular function has been used by other workers
interested in membrane transport. Rosenberg and Segal [14]
demonstrated inhibition of uptake of a variety of amino acids by
rat kidney cortex slices incubated in 3 ms't maleate. But slices
made from kidneys of rats treated with maleate did not show
such an inhibitory effect. The reason for this discrepancy
became evident when they restored normal transport in slices
treated with maleate by rinsing them in a fresh buffer, thus
showing that maleate is a readily reversible inhibitor of mem-
brane transport in vitro. Although thiol group protectors like
mercaptoethanol prevented maleate's inhibitory effect, the easy
reversibility of transport inhibition by washing treated slices
argued against a covalent link between SH groups and maleic
acid as the mechanism for this inhibition. Kinetic studies of the
effect of maleate on the uptake of aipha-aminoisohutyric acid
(AIB) showed that although maleate affected influx to a small
degree, the predominant effect was to increase the rate of efflux
from the cells. Bergeron, Dubord, and Hausser, using micro-
perfusion and stop-flow techniques in the rat, also found that
the major effect of maleate on renal transport was to increase
efflux from the renal tubule cell 151. GUnther, Silbernagl, and
Deetjen, using microperfusion and free-flow micropuncture in
rats treated with maleate, concluded that rnaleate inhibited the
influx of glycine via a saturable system and that the passive
diffusion of glycine into the renal tubule cell was unaffected
[38]. They, however, did not look directly at the efflux of amino
acids from the renal tubule cell. These observations were
consistent with the effects of maleic acid exerted on an intracel-
lular site, with the amino acid transport effects considered to be
secondary.
Heavy metal nephrotoxicity nwdel. In an early review of
urinary amino acid excretion by workers exposed to heavy
metals [39], Clarkson and Kench pointed to the frequency of
both abnormal aminoaciduria and true Fanconi syndrome ap-
pearing among workers absorbing cadmium. The relationship
between cadmium exposure and nephropathy was dramatized
by the large number of cases of itai-itai disease, caused by
contamination of the soil by cadmium, that appeared in Japan
after World War II. In addition to severe bony abnormalities
attributable to osteomalacic changes, affected individuals mani-
fested glucosuria, aminoaciduria, hyperphosphaturia. hypos-
thenuria, and renal tubular acidosis — all features of the
Fanconi syndrome. In patients who had advanced disease, the
renal histology was characterized by tubular atrophy and inter-
stitial fibrosis.
Cadmium intoxication has been studied in a variety of
species, including dog [40], rabbit [41], rat [42], and mouse [43].
In general, there is a correlation between the functional and
morphologic changes observed and the cadmium concentration
in renal cortex, the former appearing only after the cadmium
concentration exceeds 100 times normal. In cadmium-intoxicat-
ed dogs [40] and rats [44], Na-K-ATPase of renal cortex was
found to be significantly inhibited. Because this enzyme is
thought to play a role in membrane transport or organic anions,
the inhibition thus demonstrated was considered to represent
the inciting event in creation of glucosuria and aminoaciduria.
Such a postulate had been made earlier for the maleic acid
model by Kramer and Gonick [45]. But because the concentra-
tions of maleic acid and cadmium used in these studies pro-
duced mitochondrial damage at the peak of the functional
abnormalities [40—45], it is difficult to reconcile these studies
with those of Rosenberg and Segal [14] and Roth et al [46], in
which no ultrastructural changes were seen with maleate at the
time of maximum transport inhibition. Furthermore, Roth,
Goldmann, and Segal were unable to show Na-K-ATPase
inhibition by 6 mrvi maleate in isolated renal tubules of either
newborn or adult rats [16]. Any transport process relying on
oxidative phosphorylation for its energy source will be impaired
if mitochondria are damaged: what remains to he explained is
how transport processes such as these are inhibited in the
absence of such damage.
Plumbism has also been reported to induce the Fanconi
syndrome in children [47]. Aminoaciduria has been produced
by administration of lead salts to rats 1481 and rabbits [49]; once
again, ultrastructural damage to mitochondria can be correlated
with renal tubular dysfunction, a finding that calls into question
the validity of the model for study of physiologic events
occurring in the human Fanconi syndrome. It seems, therefore.
that experimental models of the human Fanconi syndrome
involving administration of heavy metals may not reflect the
actual events in vivo in the human.
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Chemical nephrotoxicity. A number of chemical substances
have been reported to cause glucosuria and aminoaciduria on
the basis of their direct nephrotoxic action. Perhaps the most
thoroughly investigated of these is the clinically relevant com-
pound. tetracycline. Following Gross's initial report in 1963 of
an individual who developed the Fanconi syndrome following
ingestion of outdated tetracycline [501. a number of other cases
appeared in the literature [51. 52]. Three degradation products
of tetracycline were known — 4-epi-tetracycline. anhydrotetra-
cycline, and anhydro-4-epi-tetracycline. Benitz and Diermeier
[53] performed a study in rats and dogs designed to determine
which of these compounds was the inciting agent, showing that
functional derangements of the kidney occurred only after
administration of anhydro-4-epi-tetracycline. Unlike the human
cases, however, in which no morphological changes in renal
tissue were demonstrated, the animals in which functional
changes were seen also showed severe tubular damage up to,
and including, sloughing of the tubules. Similarly, subsequent
studies have documented these findings [54, 55]. Once again, as
in other models, it is known that tetracyclines selectively
localize in mitochondria of hepatic and renal tubular cells.
inhibiting mitochondrial respiration by a mechanism thought to
relate to chelation of magnesium [561. Although it is possible
that doses of anhydro-4-epi-tetracycline might be found which
impair membrane transport events without causing gross mito-
chondrial and cellular damage, this relationship has gone largely
ignored. Further investigation in this area could provide valu-
able information on the interaction between oxidative metabo-
lism and active transport across the membrane barrier of the
renal tubule cell.
A variety of other chemical compounds have been associated
with the appearance of the Fanconi syndrome in humans. These
include Lysol (a mixture of cresols) [57]. nitrobenzene [58].
salicylates [591, methyl-3-chromone [601. and streptozotocin
[611. None, however, have been extensively investigated as
animal models for the human Fanconi syndrome.
Fructose-loading in the rat has been shown to affect renal
tubular and hepatic cellular metabolism in the fashion postulat-
ed for human individuals with hereditary fructose intolerance
[1, 62—65]. Fructose-loading, however, does not induce a renal
tubular dysfunction in the rat as it does in the affected human
[I], making it difficult to envision how further study of this
animal model might be expected to elucidate the biochemical
basis for the Fanconi syndrome.
Spontaneous anunal model. Recently, Bovée et at [66] re-
ported the first known cases of a spontaneous animal model of
the human Fanconi syndrome, occurring in dogs of the Basenji
breed. l'he animals presented clinically with polydipsia and
polyuria, dehydration, weight loss, and weakness. The renal
defect in these animals was represented by increased glucose
and sodium clearance in the presence of normal blood sugars.
renal aminoaciduria, and hyperphosphaturia. The urinary p0-
tassium and urate excretion were also elevated. Histologic
examination of renal tissue from these animals showed corn-
pletely normal 1:issue in dogs without renal failure and varying
degrees of tubular and glomerular damage in the others. In
addition, the authors were able to show an in vitro defect of
lysine and glycine uptake by renal cortical slices made from
biopsies of affected kidneys. This defect appeared to reside in
the processes responsible for substrate entry (influx), in con-
trast to the impaired efflux caused in rat kidney cortical slice in
vitro [14—15].
The report represents a significant advance in our study of
the biochemical etiology of the human Fanconi syndrome, since
it documents renal tubular dysfunction as a likely consequence
of genetic factors. Such a model would, therefore, allow study
of the actual disease entity, rather than an artificially created
model in which doubt always remains as to its relationship to
the disease. One can only hope that widespread screening of
animals seen in veterinary clinics throughout the world will
become the rule, in order to elicit more such animals and begin
a breeding colony.
What is known, therefore, about the underlying cellular
mechanisms that result in renal aminoacidurias does little to
clarify our understanding. The effects of maleic acid on adult rat
kidney, the most widely studied experimental model for the
human Fanconi syndrome, provide evidence of an accelerated
rate of loss of accumulated substrate [14, 15]. Similar studies in
newborn tissue have extended this finding, showing that in
immature tissue where a slow efflux rate prevails [22, 27],
maleate exerts no effect on amino acid uptake [16]. Other
studies [35, 36] have shown that maleate forms a CoA "sink"
within the cell via the succinyl CoA transferase enzyme reac-
tion but these observations could not be related to maleate's
membrane transport effects. On the other hand, in vitro studies
in tissue obtained from dogs with a presumed genetic defect in
renal amino acid reabsorption indicate the possibility that the
aminoaciduria derives from impaired luminal uptake in the renal
tubule [66]. Further study of the Fanconi dog model may
resolve many of these apparent differences.
Glucosuria
Clinical investigations. Another hallmark of the Fanconi
syndrome is glucosuria. seen with normal and even low blood
glucose concentrations, indicating that the renal threshold for
glucose is either very low or nonexistent. Yet, with glucose
loading there is a rise in the rate of reabsorption indicating that
the tubule can respond to increased loads. There are reports of
children with the Fanconi syndrome with a reduced renal
threshold for glucose, but on glucose loading have a normal
maximal glucose reabsorption rate (Tm0) [2, 67]. This normal
maximal reabsorption rate only occurred at very high plasma
glucose concentrations. In adults with the Fanconi syndrome,
low values for the renal threshold for glucose with normal to
low values for the Tm0 have also been reported [68].
This glucosuria in the Fanconi syndrome may also play a role
in the disordered handling of phosphate and amino acids
because infusions of glucose, fructose, and galactose in normal
man have resulted in phosphaturia and arninoaciduria [69]. This
effect was specific for these sugars because a similar infusion of
xylose did not produce any changes in phosphate or amino acid
handling. These patterns of glucosuria observed in the Fanconi
syndrome do not easily fit into either of the two groups
described by Reubi [70] and Bradley et at [71] in patients with
isolated glucosuria. In these glucosuric patients, one group had
a reduced renal threshold for glucose, as well as a reduced Tm0
(type A), but the second group had a reduced threshold with
exaggerated splay in the titration curve, but a normal Tm0 (type
B). L.ater reports have called into question whether these
patients actually can be separated into two distinct groups, or
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whether there is a continuum of tubule glucose reabsorption
maxima from low to normal [721. In vitro studies in the human
using cortical slices [73] and hrushhorder membrane vesicles
[74] have shown that glucose transport is an active, sodium-
dependent process mediated by one, possibly two carrier
systems. With this knowledge of glucose transport, we could
explain Reubi's type A pattern of glucosuria by a defect
lowering the maximal glucose transport velocity of the carri-
er(s) (Vmax defect), whereas type B could he a defect lowering
the affinity of glucose for the carrier (Km defect).
Laboratory inrestigattons: developmental studies in aninwi
models. Inasmuch as neither galactose 1751 nor u-methyl-D-
glucoside [22, 76] could he shown to he actively transported by
renal cortical slices from newborn rats, little is known about the
in vitro hexose transport mechanisms in immature tissue. But.
concentrative uptake of ctMG by separated renal tubules of
newborn rat kidney was subsequently demonstrated by Roth et
al [22], providing a feasible model for developmental study. In
addition to a study of the changes occurring in hexose transport
in vilro during development of the rat kidney 1771. Roth et al
have investigated the age-related changes in the effect of maleic
acid on rat kidney hexose transport 1161. These observations
suggest: (1) that a major change takes place in hexose entry
during development, unlike amino acids in which case the
primary change is in effiux: (2) that hexose transport systems
are effectively mature by 7 to 14 days in the rat, again unlike
systems for amino acid transport which require 14 to 21 days to
mature: and (3) that maleic acid creates significant perturba-
tions in hexose transport only after niaturation has occurred.
These data were thought to point to a genetically-programmed
intracellular change occurring with development which then
renders the renal tubular cell susceptible to maleate.
Because the primary in vitro effect of maleic acid on hexose
transport in adult rat kidney has been shown to be an acceler-
ated loss of accumulated substrate (effiux) 1461. the postulated
intracellular change would have to he one which related to
cellular retention, rather than to entry. This speculation has
been extended by the demonstration of Reynolds, McNamara,
and Segal [781 that maleic acid does not affect uptake of u-MG
by adult rat renal hrushborder vesicles.
Effi'cts of maleate in animal models. Silverman and H uang
[791 have used a technique known as the multiple-indicator
dilution method to study the effects of maleate on renal glucose
handling in dogs in vivo. The method consists of injection into
the renal artery of the 4C-laheled test substrate and 3H-inulin
and collection of total renal vein effluent. The renal venous
'4C13H ratio is then calculated. A ratio of less than 1 (in the
absence of 14C uptake by red cells) suggests entry or binding of
the test substance into the renal cell at the antiluminal surtce.
Simultaneous collection of urine will permit calculation of a
number of parameters including renal clearances, and so forth.
The results of this study indicated that maleic acid induces
glucosuria by three possible mechanisms: (I) by partial inhibi-
tion of D-glucose efflux from cytoplasm into blood at the
antiluminal surface: (2) by accelerated efflux of glucose from
cytoplasm into urine at the luminal brushborder surface: or, (3)
both effects combined.
In another study, utilizing micropuncture technique, Wen
[801 observed the reabsorption of approximately 90% of filtered
glucose by the canine proximal tubule in the absence of volume
expansion. The absence of volume expansion was an important
advantage in this study since increased volume and decreased
tubular transit time may. in itself, cause diuresis and naturesis,
the latter possibly affecting glucose reabsorption since the
process is thought to he sodium-dependent [81, 821. A low-dose
maleate injection (ISO mg/kg of body wt) was shown to increase
the fraction of filtered glucose delivered to distal sites but did
not cause an increase in urinary glucose. On the other hand, a
high-dose maleate injection (300 mg/kg of body wt) caused a
distinct glucosuria with fractional glucose excretion reaching
about 10%. But because the amount of filtered glucose deliv-
ered to distal sites was not increased in this case, it was
concluded that high-dose maleate injection inhibited distal
tubular reabsorption of glucose. The nature of this inhibition
was not determined, however.
in a study which combined the use of a number of techniques.
including microperfusion, micropuncture and stop-flow diure-
sis, Bergeron et al [15] demonstrated that the basis for the
maleic acid-induced glucosuria in rat kidney was an increased
rate of loss from tubular cells. The conclusions reached from
their observations point to a glucosuria resulting from maleic
acid-induced effiux of glucose at the proximal tubular site, thus
increasing glucose delivery into the distal nephron where it is
normally reabsorhed. However. maleic acid induced an in-
creased rate of efflux of glucose at the distal tubular site, as
well, thus resulting in failure to correct the defect at the
proximal site. These conclusions are completely consistent with
the observations of Wen 1801 and Silverman and Huang [79].
Spontaneous animal model. A study of fractional renal
reabsorption of glucose in dogs affected by the spontaneous
Fanconi syndrome indicates a mean of 67,3Y reabsorption
compared to controls showing a mean of 99.6% 1821. In vitro
study of u-MG uptake in slices made from renal biopsies of
affected kidneys showed marked impairment compared to con-
trols [66]. Furthermore, the significantly slower initial uptake in
affected tissue was interpreted to indicate that the defect was in
influx of u-MG into the cells. However, no effiux studies have
been published in support of these observations. These, togeth-
er with studies similar to those of Bergeron et al 1151 describing
distal tubular reabsorption function would be of great interest.
Thus, although the available data dealing with the mecha-
nisms underlying glucosuria are no less voluminous than those
for aminoaciduria, neither is an elucidation of these mecha-
nisms in the human Fanconi syndrome any closer. There is a
basic agreement among all investigators that maleic acid causes
an increase in efflux in the nephron, but the evidence from
study of the spontaneous Fanconi dog suggests quite the
opposite, that is, impaired substrate entry. The fundamental
difference will require greater future collaboration between
investigators for complete understanding of the reasons for the
discrepancy.
1-lyperphosphaturia
Clinical investigations. Hypophosphatemia is another major
feature of the Fanconi syndrome which occurs mainly from a
disorder in the renal handling of phosphate. Normally. only 10
to 20% of the filtered load of phosphate is excreted in the final
urine, In the Fanconi syndrome, this fraction is much increased
resulting in the reduced plasma levels of phosphate. Diminished
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phosphate absorption by the gastrointestinal tract does not
appear to play a major role in the hypophosphatemia [841.
The nature of the detect underlying the disordered renal
handling of phosphate remains unknown. The hulk of phos-
phate reabsorption in the kidney occurs in the proximal tubule.
Uptake of phosphate across the brushhorder membrane of the
proximal tubule cell of the rat, which is the first step of
reabsorption, was shown to be carrier-mediated and dependent
on a sodium concentration gradient directed into the cell [85--
87]. Transport of phosphate across the basal-lateral membrane,
which is the final step for reabsorption, was not dependent on a
sodium concentration gradient and may be facilitated by the
favorable negative intracellular electrical potential 185]. Further
support for this carrier-mediated model of phosphate reabsorp-
tion comes from studies done by Tenenhouse et at [88] who
found a heritable defect of phosphate transport residing at the
level of the hrushborder membrane of the proximal tubule cell
in the X-linked hypophosphatemic male mouse, an animal
model of vitarnin-D-resistant rickets in man. The phosphaturia
in the Fanconi syndrome may he related also to a defect of
phosphate transport at the level of the hrushborder membrane,
Phosphate handling by the kidney is also influenced by
parathyroid hormone (P'l'H) and possibly vitamin I). It is well
known that raised levels of PTH will cause an increase in
phosphate excretion. Morris found in a parathyroidectomized
patient with hereditary fructose intolerance that both fructose
and PTH were necessary for expression of' phosphaturia and
other elements of the Fanconi syndrome 89]. Calcium infu-
sions, which will suppress PTH secretion, have decreased
phosphate excretion in sonic studies 190—92] and not in others
[84. 93, 941. Direct measurement of PTH was found to he
normal, however, in the Fanconi syndrome [951.
Vitamin D administration in Fanconi syndrome patients leads
to increased phosphate retention. This is due in part to in-
creased phosphate absorption from the gut [84, 96—99]. Vitamin
D, or one of its polar metabolites, may also have an effect on
phosphate reabsorption in the kidney by suppressing PTHI
secretion either by a direct action on the parathyroid gland or
by raising serum calcium, through increased gut absorption of
calcium, which will then lead to decreased P'FH secretion [100].
Vitamin D, or one of its polar metaholites, may act directly on
the renal tubule to increase phosphate reabsorption 11011. The
role that PTH and vitamin D play in the phosphaturia and the
excretion of other solutes remains, however, to he defined in
the Fanconi syndrome.
Laboratory I/li'estigat!ons. Hyperexcretion of' inorganic-
phosphorus (Pi) is characteristic of both the human and experi-
mental models of the Fanconi syndrome. In the case of maleic
acid-induced phosphaturia, it is difficult to sort out the underly-
ing mechanism, since phosphate transport by brushhorder
membranes is sodiLim-dependent 185—871, and naturesis is also
induced by maleic acid [80]. It is possible that phosphaturia, as
well as glucosuria may reflect an alteration in sodium transport
created by nialeic acid. On the other hand, if defective sodium
transport underlies the other transport defects induced h
maleic acid, it is ditlicult to understand the mechanism by which
luminal uptake continues in the face of increased etfiux. be-
cause entry is, in general, sodium-dependent.
Bergeron et al [IS] have shown that maleate causes Pi. which.
like glucose and amino acids, is predominantly reabsorbed in
the proximal tubule, to leak directly into the urine at the distal
tubule site. Thus, phosphate transport appears to be affected by
maleate in the same fashion as glucose and amino acids, its
efflux increasing in the face of relatively normal entry. Fraction-
al reabsorption of Pi by the spontaneous Fanconi syndrome dog
is also decreased by about 30 compared with controls [83],
although the mechanism by which this occurs is unclear.
Other solutes
Besides glycosuria, aminoaciduria, and hypophosphatemia,
there are other signs and symptoms indicating disorders of'
solute handling by the proximal tubule. A non-delta metabolic
acidosis is a frequent finding in the Fanconi syndrome. This
metabolic acidosis is usually a proximal renal tubular acidosis
since an acid urine can be generated, but only in presence of a
low serum bicarbonate concentration 11021. In some cases, a
defect in distal acidification can also he shown by an inability to
acidify the urine even after severe acidemia 99, 102. 1031.
Hypouricemia is another common finding in the Fanconi syn-
drome, especially in adults [68, 94, 104—107]. Because uric acid
is both secreted and reabsorbed in the proximal ttibule. it is
unclear whether the secretory or reabsorptive steps or both are
affected. Sodium wasting is often seen and at times may be so
severe as to cause metabolic alkalosis in spite of the lowered
renal threshold for bicarbonate [107, 1(8]. Hypokalemia caused
by exaggerated renal loss of potassium is a constant danger to
patients with the Fanconi syndrome [103, 108—Il I]. This hypo-
kalemia can be magnified by glucose loading, hence the danger
in studying maximal glucose reabsorption. 'l'he clearance of
potassium can he as much as twice the glomerular filtration rate
indicating that net secretion of potassium can occur [112].
Proteinuria, especially small molecular weight proteins (10,000
to 50.000 daltons) consisting of enzymes. immunoglobulin light
chains, and hormones, is a frequent finding in the Fariconi
syndrome [94, 113. 114]. Larger molecular weight proteins, so
called glomerular proteinuria, can also be found in the later
stages of cystinosis and chronic intoxications as glomerular
dysfunction becomes more evident 11141.
Categories of the F'anconi syndrome
Patients with the Fanconi syndrome can be classified into two
main categories: acquired and inherited ('I'ahle 2). The major
cause of the acquired form is exogenous intoxications. Numer-
ous substances have been described which cause primarily a
tubular dysfunction, although severe intoxications can lead to
acute tubular necrosis and renal failure. The major groups of
these toxins are heavy metals, drugs and organic compounds.
Lead [39, 47, 115—1171. cadmium [39, 116, 118]. uranium [39,
119]. and mercury [39, 99, 1201 have all been associated with
tubular disorders in both adults and children. Acute lead
poisoning can lead to a complete Fanconi syndrome in children,
as well as the central nervous system disorders [47, 115, 1171, A
mild Fanconi syndrome has been seen in a IS-year-old child
following chronic mercury poisoning from a teething prepara-
tion [1201. The use of outdated tetracycline has led to a
reversible banconi syndrome and the intoxicating substance
has been shown to be anhydro-4-epitetracycline farmed from
tetracycline under the infltience of heat, moisture, and low pH
[49—521. This substance has been used to experimentally induce
a Fanconi syndrome in dogs and rats [53, 541. Methyl-3-
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Table 2. Categories of the Fanconi syndrome
Acquired Inherited
Hereditary fructose intoleranceHeavy metals
Outdated tetracycline Galactosemia
Methyl 3-chromone Tyrosinemia
Multiple myeloma Wilson's disease
Nephrotic syndrome Cystinosis
Renal transplantation Lowe's syndrome
Glycogenosis
Idiopathic
chromone (Diachrome®) has been reported to have produced a
Fanconi syndrome in a 3-year-old child [60]. Maleic acid has
been used experimentally to produce the Fanconi syndrome
[17—19, 38],
Another major cause of the acquired Fanconi syndrome are
the dysproteinemias, especially multiple myeloma [99, 104,
121—125], These disorders are extremely rare in infants and
children, however. The appearance of tubular dysfunction
seems to be associated with Bence-Jones proteinuria, although
Bence-Jones proteinuria can be seen without tubular dysfunc-
tion [126]. Experimentally, the presence of Bence-Jones pro-
teins in the media inhibited the uptake of PAH by renal cortex
slices from both rats and rabbits, whereas the presence of
proteins from nephrotic urine did not [127, 128]. Injection of
kappa-type Bence-Jones proteins into rats induced proximal
tubular lesions [129]. Besides Bence-Jones proteinuria leading
to the Fanconi syndrome, the nephrotic syndrome may, on rare
occasions, be associated with a Fanconi syndrome [130—1341.
Renal transplantation can be associated with the development
of the Fanconi syndrome either due to ischemia, graft injection,
hyperparathyroidism, or immunosuppressive therapy [135, 136]
or the recurrence of the Fanconi syndrome in the original
kidneys [137].
The inherited forms of the Fanconi syndrome include several
inborn errors of metabolism, Lowe's syndrome, and the adult
form of the Fanconi syndrome. It seems, as mentioned earlier,
although not proven, that the Fanconi syndrome associated
with the inborn errors of metabolism results from either the
accumulation of a toxin or a disturbance in energy metabolism.
The ingestion of fructose in hereditary fructose intolerance, an
autosomal recessive disorder associated with deficient activity
of fructose I-phosphate aldolase, leads to the rapid onset of
aminoaciduria associated with the accumulation of fructose I-
phosphate. Normalization of the aminoaciduria can occur with
abstension from fructose for several weeks. Similarly, the
Fanconi syndrome associated with the accumulation of galac-
tose 1-phosphate from deficient activity of galactose I-phos-
phate uridyltransferase is reversible with a galactose-free diet.
In contrast, galactosemia from deficient activity of galactose
kinase (in which impaired formation of galactose I-phosphate
occurs) is not associated with renal tubular dysfunction. Tyro-
sinemia is another inborn error of metabolism associated with
the Fanconi syndrome. The renal tubular dysfunction is revers-
ible with dietary phenylalanine and tyrosine restriction again
raising the possibility of an endogenously produced toxin.
Maleylacetoacetate, an intermediary in tyrosine metabolism,
has been proposed as a possible toxin in tyrosinemia by one
group [138]. Wilson's disease, a familial disorder of copper
metabolism, is also associated with a Fanconi syndrome which
is reversible with copper chelation by penicillamine.
Other inborn errors of metabolism are associated with the
Fanconi syndrome, but the role of a toxin is less clear.
Cystinosis, an autosomal recessive disorder associated with the
intracellular accumulation of cystine, initially presents with the
Fanconi syndrome at age 3 to 6 months. With time, glomerular
failure overtakes the tubular disorder and results in end-stage
renal failure. It has been proposed that the raised concentra-
tions of intracellular cystine cause the renal dysfunction; yet,
the concentrations of cystine in fetal tissue are comparable to
those found at the time of renal transplantation [139, 140]. The
Fanconi syndrome is a major feature of oculo-cerebro-renal
syndrome (Lowe's syndrome), although the pathogenesis of
this disorder remains an enigma. The Fanconi syndrome has
been associated with a specific type of glycogen storage disease
of which the enzymatic defect remains to be characterized [111,
141, 1421. It appears to be inherited as an autosomal recessive
tract. The Fanconi syndrome associated with it is usually
severe, with striking glucosuria. The Fanconi syndrome may
even precede the appearance of hepatomegaly.
A primary form of the Fanconi syndrome is the adult or
idiopathic type [94, 97—99, 104, 137]. As the name implies, this
type is diagnosed only by exclusion of the known diseases and
toxins associated with the Fanconi syndrome. Originally, it was
thought to occur only in adults, but it has been well documented
in children [107, 141. 142]. It usually occurs sporadically but
has been observed to follow both an autosomal dominant [143]
and an autosomal recessive [144] mode of inheritance. It even
has appeared to have an X-linked pattern of inheritance [1451.
The prognosis is uncertain with some patients developing
chronic renal insufficiency over a period of 10 to 30 years.
Recurrence of the Fanconi syndrome in the patient who had
received a renal transplant and had no evidence of rejection
suggests a primary abnormality that was extrarenal [137]. The
idiopathic Fanconi syndrome may be related to extrarenal
factors in some patients, but in others it may be related to a
basic defect in membrane function.
In the final analysis we have presented an interim assessment
of our knowledge of the Fanconi syndrome. There are many
unsolved questions whose answers are basic to a complete
understanding of the syndrome. Clearly the human renal proxi-
mal tubule cells perform carrier-mediated transport. In vivo
function studies in affected patients are difficult to interpret
because of the bipolar nature of solute transport carried out by
renal tubule epithelium and the possible directional components
of transport defects. Thus, from a physiologic point of view, we
do not yet know whether the human Fanconi syndrome results
from (1) defective influx of solutes at the luminal (brushborder)
surface of the proximal tubule cell, (2) increased rate of efflux or
back diffusion at the luminal surface, or (3) diminished rate of
transport of solutes out of the cells at the antiluminal (basal-
lateral) surface, a process which could result in the back
diffusion mentioned above. From a biochemical and chemical
viewpoint, it is still unclear whether there is impaired energy
production by the cells or defective energy transduction to
membrane transport processes; alternatively, there may be
abnormalities in the structure or composition of the renal
membranes, which result in the observed defects in transport
function.
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To skirt the difficulties in obtaining human tissue for study,
investigators have used animal models to explore possible
mechanisms. Whether these models are indeed representative
of and the experimental observations applicable to the human
Fanconi syndrome cannot be answered at present. The recent
delineation of a spontaneous dog Fanconi syndrome may he
more helpful than the toxin-induced model in explaining the
syndrome. The basic derangement explaining the global trans-
port dysfunction of the Fanconi syndrome will be discerned by
the application of numerous and varied physiological and
biochemical approaches to the study of renal membrane struc-
ture and function. The ability to isolate and study renal brush-
border and basolateral membranes offers great potential for
solving the present enigma of the Fanconi syndrome.
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